• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.

作者信息

Morè Sonia, Federici Irene, Bossi Alessandra, Rupoli Serena, Morsia Erika, Manieri Valentina M, Olivieri Attilio, Petrucci Maria T, Fazio Francesca, Lisi Chiara, Sorella Silvia, Paoli Adele D, Farina Francesca, Mele Anna, De Francesco Rossella, Greco Antonino, Fioritoni Francesca, Liberatore Carmine, di Toritto Tommaso Caravita, Tordi Attilio, Rago Angela, Siniscalchi Agostina, Brunori Marino, Sgherza Nicola, Musto Pellegrino, Amendola Angela, Vacca Angelo, Solimando Antonio G, Melaccio Assunta, Palma Antonio, Melillo Lorella M A, Ciuffreda Lucia, Gentili Silvia, Buda Gabriele, Del Giudice Maria L, Falcone Antonietta P, Tosi Patrizia, Tomassetti Simona, Rotondo Francesco, Gozzetti Alessandro, Galieni Piero, Ruggieri Miriana, Frigeri Ferdinando, Bianco Rosario, Lombardo Alessandra, Trastulli Fabio, Corvatta Laura, Zizzo Carmela, Duro Giovanni, Offidani Massimo

机构信息

Hematology Unit, AOU delle Marche Ancona Italy.

Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I Sapienza University of Rome Rome Italy.

出版信息

Hemasphere. 2025 Jan 22;9(1):e70079. doi: 10.1002/hem3.70079. eCollection 2025 Jan.

DOI:10.1002/hem3.70079
PMID:39850649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11754764/
Abstract
摘要

相似文献

1
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.冒烟型或多发性骨髓瘤患者中I型戈谢病的患病率：前瞻性观察性CHAGAL研究结果
Hemasphere. 2025 Jan 22;9(1):e70079. doi: 10.1002/hem3.70079. eCollection 2025 Jan.
2
Correction to Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study.对“冒烟型或多发性骨髓瘤患者中I型戈谢病的患病率：前瞻性观察性CHAGAL研究结果”的勘误
Hemasphere. 2025 May 14;9(5):e70142. doi: 10.1002/hem3.70142. eCollection 2025 May.
3
Regression of smoldering myeloma with treatment of Gaucher disease.戈谢病治疗后冒烟型骨髓瘤的消退
Blood Adv. 2024 Apr 9;8(7):1634-1638. doi: 10.1182/bloodadvances.2023012304.
4
Synchronous multiple myeloma and Gaucher disease.同步性多发性骨髓瘤与戈谢病。
Hematol Oncol Stem Cell Ther. 2020 Mar;13(1):42-45. doi: 10.1016/j.hemonc.2019.07.001. Epub 2019 Oct 9.
5
Effects of Amyloid Light-Chain Amyloidosis on Clinical Characteristics and Prognosis in Multiple Myeloma: A Single-Center Retrospective Study.淀粉样轻链淀粉样变性对多发性骨髓瘤临床特征及预后的影响：一项单中心回顾性研究
Cancer Manag Res. 2021 Feb 11;13:1343-1356. doi: 10.2147/CMAR.S287922. eCollection 2021.
6
Four genes predict high risk of progression from smoldering to symptomatic multiple myeloma (SWOG S0120).四个基因可预测无症状多发性骨髓瘤进展为有症状多发性骨髓瘤的高风险（SWOG S0120）。
Haematologica. 2015 Sep;100(9):1214-21. doi: 10.3324/haematol.2015.124651. Epub 2015 May 28.
7
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.卡非佐米、来那度胺和地塞米松治疗后序贯来那度胺维持治疗高危冒烟型骨髓瘤患者预防症状性多发性骨髓瘤的Ⅱ期非随机对照试验
JAMA Oncol. 2021 Nov 1;7(11):1678-1685. doi: 10.1001/jamaoncol.2021.3971.
8
Baseline mutational patterns and sustained MRD negativity in patients with high-risk smoldering myeloma.高危冒烟型骨髓瘤患者的基线突变模式与持续微小残留病阴性
Blood Adv. 2017 Sep 29;1(22):1911-1918. doi: 10.1182/bloodadvances.2017005934. eCollection 2017 Oct 10.
9
High-risk smoldering myeloma versus early detection of multiple myeloma: Current models, goals of therapy, and clinical implications.高危冒烟型骨髓瘤与多发性骨髓瘤的早期检测：当前模型、治疗目标及临床意义。
Best Pract Res Clin Haematol. 2020 Mar;33(1):101152. doi: 10.1016/j.beha.2020.101152. Epub 2020 Jan 25.
10
Timing of acquisition of deletion 13 in plasma cell dyscrasias is dependent on genetic context.浆细胞异常增生中缺失 13 获得的时间取决于遗传背景。
Haematologica. 2009 Dec;94(12):1708-13. doi: 10.3324/haematol.2009.011064.

本文引用的文献

1
Regression of smoldering myeloma with treatment of Gaucher disease.戈谢病治疗后冒烟型骨髓瘤的消退
Blood Adv. 2024 Apr 9;8(7):1634-1638. doi: 10.1182/bloodadvances.2023012304.
2
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance.戈谢病在 600 例意义未明的单克隆丙种球蛋白血症患者中的流行情况。
Eur J Haematol. 2023 Dec;111(6):922-929. doi: 10.1111/ejh.14105. Epub 2023 Sep 25.
3
A synchronous therapy with daratumumab and enzymatic replacement therapy (ERT) in a patient with Gaucher disease and multiple myeloma.在一名患有戈谢病和多发性骨髓瘤的患者中，达雷妥尤单抗与酶替代疗法（ERT）同步治疗。
Ann Hematol. 2023 Oct;102(10):2977-2978. doi: 10.1007/s00277-023-05319-x. Epub 2023 Jul 11.
4
Global Incidence and Prevalence of Gaucher Disease: A Targeted Literature Review.戈谢病的全球发病率和患病率：一项针对性文献综述。
J Clin Med. 2022 Dec 22;12(1):85. doi: 10.3390/jcm12010085.
5
Potential Role of Sphingolipidoses-Associated Lysosphingolipids in Cancer.鞘脂贮积症相关溶血鞘脂类在癌症中的潜在作用。
Cancers (Basel). 2022 Oct 5;14(19):4858. doi: 10.3390/cancers14194858.
6
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry.2123 例戈谢氏病 1 型患者的癌症风险和丙种球蛋白异常在国际戈谢氏病组织戈谢氏病注册研究中的表现。
Am J Hematol. 2022 Oct;97(10):1337-1347. doi: 10.1002/ajh.26675. Epub 2022 Aug 24.
7
Multiple myeloma: 2022 update on diagnosis, risk stratification, and management.多发性骨髓瘤：2022 年诊断、风险分层和治疗的更新。
Am J Hematol. 2022 Aug;97(8):1086-1107. doi: 10.1002/ajh.26590. Epub 2022 May 23.
8
The SPID-GBA study: Sex distribution, Penetrance, Incidence, and Dementia in GBA-PD.SPID-GBA研究：GBA-PD中的性别分布、外显率、发病率与痴呆症
Neurol Genet. 2020 Oct 20;6(6):e523. doi: 10.1212/NXG.0000000000000523. eCollection 2020 Dec.
9
Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma.骨髓瘤起源中针对溶血磷脂的克隆性免疫球蛋白。
N Engl J Med. 2016 Feb 11;374(6):555-61. doi: 10.1056/NEJMoa1508808.
10
NKT-dependent B-cell activation in Gaucher disease.戈谢氏病中 NKT 细胞依赖的 B 细胞激活。
Blood. 2015 Feb 19;125(8):1200-2. doi: 10.1182/blood-2014-12-617514.